InVision AG
InVision AG (IVX.DE) Stock Competitors & Peer Comparison
See (IVX.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Application Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IVX.DE | €6.00 | -2.44% | 13.4M | -4.48 | -€1.34 | N/A |
| SAP.DE | €148.02 | +3.83% | 171.7B | 24.10 | €6.10 | +1.60% |
| FOO.DE | €162.48 | +3.77% | 152.6B | 23.79 | €6.76 | +0.89% |
| FOO.F | €161.78 | +3.04% | 148.6B | 23.40 | €6.77 | +0.90% |
| 307.F | €97.70 | +1.66% | 128.3B | 118.33 | €0.82 | N/A |
| ITU.DE | €376.95 | +4.07% | 103.4B | 28.00 | €13.33 | +1.04% |
| CDS.DE | €237.45 | +1.04% | 64.1B | 67.35 | €3.49 | N/A |
| AUD.DE | €206.00 | +3.55% | 43.6B | 45.59 | €4.50 | N/A |
| 5ZM.F | €68.62 | +1.49% | 19.9B | 12.55 | €5.35 | N/A |
| FFV.DE | €297.70 | +0.40% | 17.4B | 53.83 | €5.53 | N/A |
Stock Comparison
IVX.DE vs SAP.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, SAP.DE has a market cap of 171.7B. Regarding current trading prices, IVX.DE is priced at €6.00, while SAP.DE trades at €148.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas SAP.DE's P/E ratio is 24.10. In terms of profitability, IVX.DE's ROE is -0.40%, compared to SAP.DE's ROE of +0.17%. Regarding short-term risk, IVX.DE is less volatile compared to SAP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check SAP.DE's competition here
IVX.DE vs FOO.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FOO.DE has a market cap of 152.6B. Regarding current trading prices, IVX.DE is priced at €6.00, while FOO.DE trades at €162.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FOO.DE's P/E ratio is 23.79. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FOO.DE's ROE of +0.12%. Regarding short-term risk, IVX.DE is less volatile compared to FOO.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FOO.DE's competition here
IVX.DE vs FOO.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FOO.F has a market cap of 148.6B. Regarding current trading prices, IVX.DE is priced at €6.00, while FOO.F trades at €161.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FOO.F's P/E ratio is 23.40. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FOO.F's ROE of +0.12%. Regarding short-term risk, IVX.DE is less volatile compared to FOO.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FOO.F's competition here
IVX.DE vs 307.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 307.F has a market cap of 128.3B. Regarding current trading prices, IVX.DE is priced at €6.00, while 307.F trades at €97.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 307.F's P/E ratio is 118.33. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 307.F's ROE of +0.10%. Regarding short-term risk, IVX.DE and 307.F have similar daily volatility (0.00).Check 307.F's competition here
IVX.DE vs ITU.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ITU.DE has a market cap of 103.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while ITU.DE trades at €376.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ITU.DE's P/E ratio is 28.00. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ITU.DE's ROE of +0.22%. Regarding short-term risk, IVX.DE is less volatile compared to ITU.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ITU.DE's competition here
IVX.DE vs CDS.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CDS.DE has a market cap of 64.1B. Regarding current trading prices, IVX.DE is priced at €6.00, while CDS.DE trades at €237.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CDS.DE's P/E ratio is 67.35. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CDS.DE's ROE of +0.22%. Regarding short-term risk, IVX.DE is less volatile compared to CDS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check CDS.DE's competition here
IVX.DE vs AUD.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, AUD.DE has a market cap of 43.6B. Regarding current trading prices, IVX.DE is priced at €6.00, while AUD.DE trades at €206.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas AUD.DE's P/E ratio is 45.59. In terms of profitability, IVX.DE's ROE is -0.40%, compared to AUD.DE's ROE of +0.40%. Regarding short-term risk, IVX.DE is less volatile compared to AUD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check AUD.DE's competition here
IVX.DE vs 5ZM.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 5ZM.F has a market cap of 19.9B. Regarding current trading prices, IVX.DE is priced at €6.00, while 5ZM.F trades at €68.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 5ZM.F's P/E ratio is 12.55. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 5ZM.F's ROE of +0.21%. Regarding short-term risk, IVX.DE and 5ZM.F have similar daily volatility (0.00).Check 5ZM.F's competition here
IVX.DE vs FFV.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FFV.DE has a market cap of 17.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while FFV.DE trades at €297.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FFV.DE's P/E ratio is 53.83. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FFV.DE's ROE of +0.20%. Regarding short-term risk, IVX.DE is less volatile compared to FFV.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FFV.DE's competition here
IVX.DE vs CTX.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CTX.DE has a market cap of 13.5B. Regarding current trading prices, IVX.DE is priced at €6.00, while CTX.DE trades at €106.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CTX.DE's P/E ratio is 39.97. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CTX.DE's ROE of +0.93%. Regarding short-term risk, IVX.DE and CTX.DE have similar daily volatility (0.00).Check CTX.DE's competition here
IVX.DE vs E3G1.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, E3G1.SG has a market cap of 10.4B. Regarding current trading prices, IVX.DE is priced at €6.00, while E3G1.SG trades at €52.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas E3G1.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to E3G1.SG's ROE of +0.27%. Regarding short-term risk, IVX.DE is less volatile compared to E3G1.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check E3G1.SG's competition here
IVX.DE vs NEM.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, NEM.DE has a market cap of 7.2B. Regarding current trading prices, IVX.DE is priced at €6.00, while NEM.DE trades at €62.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas NEM.DE's P/E ratio is 35.42. In terms of profitability, IVX.DE's ROE is -0.40%, compared to NEM.DE's ROE of +0.25%. Regarding short-term risk, IVX.DE is less volatile compared to NEM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check NEM.DE's competition here
IVX.DE vs US44891N2080.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, US44891N2080.SG has a market cap of 2.1B. Regarding current trading prices, IVX.DE is priced at €6.00, while US44891N2080.SG trades at €29.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas US44891N2080.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to US44891N2080.SG's ROE of +0.00%. Regarding short-term risk, IVX.DE and US44891N2080.SG have similar daily volatility (0.00).Check US44891N2080.SG's competition here
IVX.DE vs RKET.HM Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, RKET.HM has a market cap of 2B. Regarding current trading prices, IVX.DE is priced at €6.00, while RKET.HM trades at €24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas RKET.HM's P/E ratio is 1.45. In terms of profitability, IVX.DE's ROE is -0.40%, compared to RKET.HM's ROE of +0.24%. Regarding short-term risk, IVX.DE is less volatile compared to RKET.HM. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check RKET.HM's competition here
IVX.DE vs AOF.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, AOF.DE has a market cap of 1.2B. Regarding current trading prices, IVX.DE is priced at €6.00, while AOF.DE trades at €75.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas AOF.DE's P/E ratio is 24.24. In terms of profitability, IVX.DE's ROE is -0.40%, compared to AOF.DE's ROE of +0.59%. Regarding short-term risk, IVX.DE is less volatile compared to AOF.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check AOF.DE's competition here
IVX.DE vs M8G.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, M8G.DE has a market cap of 710.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while M8G.DE trades at €3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas M8G.DE's P/E ratio is 27.13. In terms of profitability, IVX.DE's ROE is -0.40%, compared to M8G.DE's ROE of +0.03%. Regarding short-term risk, IVX.DE is less volatile compared to M8G.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check M8G.DE's competition here
IVX.DE vs VRF.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, VRF.DE has a market cap of 710.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while VRF.DE trades at €3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas VRF.DE's P/E ratio is 27.13. In terms of profitability, IVX.DE's ROE is -0.40%, compared to VRF.DE's ROE of +0.05%. Regarding short-term risk, IVX.DE is less volatile compared to VRF.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check VRF.DE's competition here
IVX.DE vs M8G.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, M8G.F has a market cap of 706.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while M8G.F trades at €3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas M8G.F's P/E ratio is 26.96. In terms of profitability, IVX.DE's ROE is -0.40%, compared to M8G.F's ROE of +0.05%. Regarding short-term risk, IVX.DE is less volatile compared to M8G.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check M8G.F's competition here
IVX.DE vs PSAN.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, PSAN.DE has a market cap of 698.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while PSAN.DE trades at €45.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas PSAN.DE's P/E ratio is -30.27. In terms of profitability, IVX.DE's ROE is -0.40%, compared to PSAN.DE's ROE of -0.26%. Regarding short-term risk, IVX.DE is less volatile compared to PSAN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check PSAN.DE's competition here
IVX.DE vs TMV.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TMV.DE has a market cap of 697.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while TMV.DE trades at €4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TMV.DE's P/E ratio is 6.09. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TMV.DE's ROE of +0.96%. Regarding short-term risk, IVX.DE is less volatile compared to TMV.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check TMV.DE's competition here
IVX.DE vs GKS.HM Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, GKS.HM has a market cap of 647.8M. Regarding current trading prices, IVX.DE is priced at €6.00, while GKS.HM trades at €285.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas GKS.HM's P/E ratio is -123.38. In terms of profitability, IVX.DE's ROE is -0.40%, compared to GKS.HM's ROE of -0.06%. Regarding short-term risk, IVX.DE and GKS.HM have similar daily volatility (0.00).Check GKS.HM's competition here
IVX.DE vs 0S6.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 0S6.DE has a market cap of 576M. Regarding current trading prices, IVX.DE is priced at €6.00, while 0S6.DE trades at €14.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 0S6.DE's P/E ratio is -2.17. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 0S6.DE's ROE of -0.13%. Regarding short-term risk, IVX.DE is less volatile compared to 0S6.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 0S6.DE's competition here
IVX.DE vs MUM.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, MUM.DE has a market cap of 552.4M. Regarding current trading prices, IVX.DE is priced at €6.00, while MUM.DE trades at €34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas MUM.DE's P/E ratio is 17.57. In terms of profitability, IVX.DE's ROE is -0.40%, compared to MUM.DE's ROE of +0.38%. Regarding short-term risk, IVX.DE is less volatile compared to MUM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check MUM.DE's competition here
IVX.DE vs GKS.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, GKS.DE has a market cap of 494.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while GKS.DE trades at €219.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas GKS.DE's P/E ratio is -44.88. In terms of profitability, IVX.DE's ROE is -0.40%, compared to GKS.DE's ROE of -0.06%. Regarding short-term risk, IVX.DE is less volatile compared to GKS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check GKS.DE's competition here
IVX.DE vs IVU.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, IVU.DE has a market cap of 306M. Regarding current trading prices, IVX.DE is priced at €6.00, while IVU.DE trades at €18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas IVU.DE's P/E ratio is 22.99. In terms of profitability, IVX.DE's ROE is -0.40%, compared to IVU.DE's ROE of +0.15%. Regarding short-term risk, IVX.DE is less volatile compared to IVU.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check IVU.DE's competition here
IVX.DE vs VRV.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, VRV.DE has a market cap of 268.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while VRV.DE trades at €1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas VRV.DE's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to VRV.DE's ROE of +0.00%. Regarding short-term risk, IVX.DE is less volatile compared to VRV.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check VRV.DE's competition here
IVX.DE vs DBD.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, DBD.DE has a market cap of 233.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while DBD.DE trades at €2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas DBD.DE's P/E ratio is -0.96. In terms of profitability, IVX.DE's ROE is -0.40%, compared to DBD.DE's ROE of +0.53%. Regarding short-term risk, IVX.DE is less volatile compared to DBD.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check DBD.DE's competition here
IVX.DE vs MSGL.HM Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, MSGL.HM has a market cap of 163.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while MSGL.HM trades at €3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas MSGL.HM's P/E ratio is 13.64. In terms of profitability, IVX.DE's ROE is -0.40%, compared to MSGL.HM's ROE of +0.16%. Regarding short-term risk, IVX.DE and MSGL.HM have similar daily volatility (0.00).Check MSGL.HM's competition here
IVX.DE vs SJJ.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, SJJ.DE has a market cap of 129.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while SJJ.DE trades at €12.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas SJJ.DE's P/E ratio is 112.27. In terms of profitability, IVX.DE's ROE is -0.40%, compared to SJJ.DE's ROE of +0.01%. Regarding short-term risk, IVX.DE is less volatile compared to SJJ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check SJJ.DE's competition here
IVX.DE vs 52D0.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 52D0.F has a market cap of 121.2M. Regarding current trading prices, IVX.DE is priced at €6.00, while 52D0.F trades at €0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 52D0.F's P/E ratio is -4.56. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 52D0.F's ROE of -0.70%. Regarding short-term risk, IVX.DE is less volatile compared to 52D0.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 52D0.F's competition here
IVX.DE vs FAA.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, FAA.DE has a market cap of 115.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while FAA.DE trades at €10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas FAA.DE's P/E ratio is 13.97. In terms of profitability, IVX.DE's ROE is -0.40%, compared to FAA.DE's ROE of +0.24%. Regarding short-term risk, IVX.DE is less volatile compared to FAA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check FAA.DE's competition here
IVX.DE vs TPG.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TPG.DE has a market cap of 105.4M. Regarding current trading prices, IVX.DE is priced at €6.00, while TPG.DE trades at €5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TPG.DE's P/E ratio is 2.28. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TPG.DE's ROE of +0.30%. Regarding short-term risk, IVX.DE is less volatile compared to TPG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check TPG.DE's competition here
IVX.DE vs BSS.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, BSS.F has a market cap of 102.1M. Regarding current trading prices, IVX.DE is priced at €6.00, while BSS.F trades at €22.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas BSS.F's P/E ratio is 55.50. In terms of profitability, IVX.DE's ROE is -0.40%, compared to BSS.F's ROE of +0.14%. Regarding short-term risk, IVX.DE is less volatile compared to BSS.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check BSS.F's competition here
IVX.DE vs V3S.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, V3S.DE has a market cap of 98.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while V3S.DE trades at €12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas V3S.DE's P/E ratio is -43.75. In terms of profitability, IVX.DE's ROE is -0.40%, compared to V3S.DE's ROE of -0.04%. Regarding short-term risk, IVX.DE is less volatile compared to V3S.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check V3S.DE's competition here
IVX.DE vs ESY.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ESY.DE has a market cap of 87.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while ESY.DE trades at €13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ESY.DE's P/E ratio is -18.71. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ESY.DE's ROE of -0.07%. Regarding short-term risk, IVX.DE is less volatile compared to ESY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ESY.DE's competition here
IVX.DE vs 27H.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 27H.F has a market cap of 68.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while 27H.F trades at €0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 27H.F's P/E ratio is -3.23. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 27H.F's ROE of -0.45%. Regarding short-term risk, IVX.DE is less volatile compared to 27H.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 27H.F's competition here
IVX.DE vs TPG0.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TPG0.DE has a market cap of 57.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while TPG0.DE trades at €2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TPG0.DE's P/E ratio is 1.24. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TPG0.DE's ROE of +0.00%. Regarding short-term risk, IVX.DE is less volatile compared to TPG0.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check TPG0.DE's competition here
IVX.DE vs CSH.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CSH.DE has a market cap of 50.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while CSH.DE trades at €6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CSH.DE's P/E ratio is -11.05. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CSH.DE's ROE of -0.12%. Regarding short-term risk, IVX.DE is less volatile compared to CSH.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check CSH.DE's competition here
IVX.DE vs TR9.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TR9.F has a market cap of 36.2M. Regarding current trading prices, IVX.DE is priced at €6.00, while TR9.F trades at €18.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TR9.F's P/E ratio is -41.09. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TR9.F's ROE of -0.27%. Regarding short-term risk, IVX.DE and TR9.F have similar daily volatility (0.00).Check TR9.F's competition here
IVX.DE vs TR9.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TR9.DE has a market cap of 33.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while TR9.DE trades at €17.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TR9.DE's P/E ratio is -38.15. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TR9.DE's ROE of -0.27%. Regarding short-term risk, IVX.DE and TR9.DE have similar daily volatility (0.00).Check TR9.DE's competition here
IVX.DE vs 1OJ.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 1OJ.F has a market cap of 30.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while 1OJ.F trades at €0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 1OJ.F's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 1OJ.F's ROE of -0.45%. Regarding short-term risk, IVX.DE and 1OJ.F have similar daily volatility (0.00).Check 1OJ.F's competition here
IVX.DE vs 1OJ.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 1OJ.SG has a market cap of 30.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while 1OJ.SG trades at €0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 1OJ.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 1OJ.SG's ROE of +0.07%. Regarding short-term risk, IVX.DE is less volatile compared to 1OJ.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 1OJ.SG's competition here
IVX.DE vs VRL.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, VRL.DE has a market cap of 29.6M. Regarding current trading prices, IVX.DE is priced at €6.00, while VRL.DE trades at €13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas VRL.DE's P/E ratio is -29.36. In terms of profitability, IVX.DE's ROE is -0.40%, compared to VRL.DE's ROE of -0.88%. Regarding short-term risk, IVX.DE is less volatile compared to VRL.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check VRL.DE's competition here
IVX.DE vs US37892C1062.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, US37892C1062.SG has a market cap of 24.2M. Regarding current trading prices, IVX.DE is priced at €6.00, while US37892C1062.SG trades at €1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas US37892C1062.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to US37892C1062.SG's ROE of +0.00%. Regarding short-term risk, IVX.DE is less volatile compared to US37892C1062.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check US37892C1062.SG's competition here
IVX.DE vs NIIN.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, NIIN.DE has a market cap of 23.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while NIIN.DE trades at €0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas NIIN.DE's P/E ratio is -6.60. In terms of profitability, IVX.DE's ROE is -0.40%, compared to NIIN.DE's ROE of -0.25%. Regarding short-term risk, IVX.DE is less volatile compared to NIIN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check NIIN.DE's competition here
IVX.DE vs TBX.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TBX.F has a market cap of 18.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while TBX.F trades at €8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TBX.F's P/E ratio is 10.93. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TBX.F's ROE of +0.32%. Regarding short-term risk, IVX.DE and TBX.F have similar daily volatility (0.00).Check TBX.F's competition here
IVX.DE vs TBX0.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, TBX0.F has a market cap of 17.2M. Regarding current trading prices, IVX.DE is priced at €6.00, while TBX0.F trades at €7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas TBX0.F's P/E ratio is 8.14. In terms of profitability, IVX.DE's ROE is -0.40%, compared to TBX0.F's ROE of +0.46%. Regarding short-term risk, IVX.DE is less volatile compared to TBX0.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check TBX0.F's competition here
IVX.DE vs 31M.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 31M.SG has a market cap of 16.1M. Regarding current trading prices, IVX.DE is priced at €6.00, while 31M.SG trades at €0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 31M.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 31M.SG's ROE of +4.35%. Regarding short-term risk, IVX.DE is less volatile compared to 31M.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 31M.SG's competition here
IVX.DE vs ISHA.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ISHA.DE has a market cap of 15.8M. Regarding current trading prices, IVX.DE is priced at €6.00, while ISHA.DE trades at €1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ISHA.DE's P/E ratio is -4.86. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ISHA.DE's ROE of -0.31%. Regarding short-term risk, IVX.DE is less volatile compared to ISHA.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ISHA.DE's competition here
IVX.DE vs C1V0.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, C1V0.DE has a market cap of 14.7M. Regarding current trading prices, IVX.DE is priced at €6.00, while C1V0.DE trades at €7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas C1V0.DE's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to C1V0.DE's ROE of +0.00%. Regarding short-term risk, IVX.DE is less volatile compared to C1V0.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check C1V0.DE's competition here
IVX.DE vs BWQ.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, BWQ.DE has a market cap of 14.3M. Regarding current trading prices, IVX.DE is priced at €6.00, while BWQ.DE trades at €3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas BWQ.DE's P/E ratio is 7.69. In terms of profitability, IVX.DE's ROE is -0.40%, compared to BWQ.DE's ROE of +0.07%. Regarding short-term risk, IVX.DE is less volatile compared to BWQ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check BWQ.DE's competition here
IVX.DE vs DTD2.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, DTD2.DE has a market cap of 11.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while DTD2.DE trades at €1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas DTD2.DE's P/E ratio is 8.30. In terms of profitability, IVX.DE's ROE is -0.40%, compared to DTD2.DE's ROE of +0.09%. Regarding short-term risk, IVX.DE is less volatile compared to DTD2.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check DTD2.DE's competition here
IVX.DE vs 9DR.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 9DR.SG has a market cap of 8.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while 9DR.SG trades at €0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 9DR.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 9DR.SG's ROE of -0.26%. Regarding short-term risk, IVX.DE is less volatile compared to 9DR.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 9DR.SG's competition here
IVX.DE vs 8DQ.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 8DQ.F has a market cap of 6.9M. Regarding current trading prices, IVX.DE is priced at €6.00, while 8DQ.F trades at €0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 8DQ.F's P/E ratio is -0.07. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 8DQ.F's ROE of -0.53%. Regarding short-term risk, IVX.DE and 8DQ.F have similar daily volatility (0.00).Check 8DQ.F's competition here
IVX.DE vs ABX.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, ABX.DE has a market cap of 6.4M. Regarding current trading prices, IVX.DE is priced at €6.00, while ABX.DE trades at €1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas ABX.DE's P/E ratio is -2.91. In terms of profitability, IVX.DE's ROE is -0.40%, compared to ABX.DE's ROE of -0.26%. Regarding short-term risk, IVX.DE is less volatile compared to ABX.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check ABX.DE's competition here
IVX.DE vs 2LH.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 2LH.F has a market cap of 4.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while 2LH.F trades at €1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 2LH.F's P/E ratio is -43.85. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 2LH.F's ROE of -0.01%. Regarding short-term risk, IVX.DE is less volatile compared to 2LH.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 2LH.F's competition here
IVX.DE vs CPU2.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CPU2.F has a market cap of 3.5M. Regarding current trading prices, IVX.DE is priced at €6.00, while CPU2.F trades at €0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CPU2.F's P/E ratio is -78.00. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CPU2.F's ROE of -0.19%. Regarding short-term risk, IVX.DE is less volatile compared to CPU2.F. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check CPU2.F's competition here
IVX.DE vs JE00B1Z48326.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, JE00B1Z48326.SG has a market cap of 1.2M. Regarding current trading prices, IVX.DE is priced at €6.00, while JE00B1Z48326.SG trades at €0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas JE00B1Z48326.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to JE00B1Z48326.SG's ROE of +0.00%. Regarding short-term risk, IVX.DE is less volatile compared to JE00B1Z48326.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check JE00B1Z48326.SG's competition here
IVX.DE vs 223.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 223.SG has a market cap of 1.1M. Regarding current trading prices, IVX.DE is priced at €6.00, while 223.SG trades at €0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 223.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 223.SG's ROE of -0.59%. Regarding short-term risk, IVX.DE is less volatile compared to 223.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check 223.SG's competition here
IVX.DE vs PLARTGS00019.SG Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, PLARTGS00019.SG has a market cap of 511.9K. Regarding current trading prices, IVX.DE is priced at €6.00, while PLARTGS00019.SG trades at €0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas PLARTGS00019.SG's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to PLARTGS00019.SG's ROE of +0.00%. Regarding short-term risk, IVX.DE is less volatile compared to PLARTGS00019.SG. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check PLARTGS00019.SG's competition here
IVX.DE vs 9J4.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 9J4.F has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while 9J4.F trades at €0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 9J4.F's P/E ratio is -1.49. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 9J4.F's ROE of -0.37%. Regarding short-term risk, IVX.DE and 9J4.F have similar daily volatility (0.00).Check 9J4.F's competition here
IVX.DE vs SC2.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, SC2.DE has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while SC2.DE trades at €50.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas SC2.DE's P/E ratio is -168.31. In terms of profitability, IVX.DE's ROE is -0.40%, compared to SC2.DE's ROE of -0.01%. Regarding short-term risk, IVX.DE and SC2.DE have similar daily volatility (0.00).Check SC2.DE's competition here
IVX.DE vs 1HD.F Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, 1HD.F has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while 1HD.F trades at €0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas 1HD.F's P/E ratio is -21.59. In terms of profitability, IVX.DE's ROE is -0.40%, compared to 1HD.F's ROE of N/A. Regarding short-term risk, IVX.DE and 1HD.F have similar daily volatility (0.00).Check 1HD.F's competition here
IVX.DE vs CAP.DE Comparison March 2026
IVX.DE plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVX.DE stands at 13.4M. In comparison, CAP.DE has a market cap of 0. Regarding current trading prices, IVX.DE is priced at €6.00, while CAP.DE trades at €3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVX.DE currently has a P/E ratio of -4.48, whereas CAP.DE's P/E ratio is N/A. In terms of profitability, IVX.DE's ROE is -0.40%, compared to CAP.DE's ROE of +0.10%. Regarding short-term risk, IVX.DE is less volatile compared to CAP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for IVX.DE.Check CAP.DE's competition here